文献速递胸部CT

单次增强双能CT静脉期扫描可区分肺鳞状细胞癌与腺癌

A Single Enhanced Dual-Energy CT Scan May Distinguish Lung Squamous Cell Carcinoma From Adenocarcinoma During the Venous phase.
PubMed 文献 · Acad Radiol · 2019-08-22

研究纳入62例肺癌患者(32例鳞癌、30例腺癌),行双期增强双能CT,测量动脉期与静脉期的碘浓度、标准化碘浓度及曲线斜率。腺癌各项参数均高于鳞癌,但仅静脉期差异有统计学意义;静脉期碘浓度鉴别鳞癌与腺癌的AUC为0.871。

要点

  • 静脉期碘浓度鉴别肺鳞癌与腺癌的AUC为0.871,敏感度81.2%、特异度83.3%。
  • 动脉期碘浓度、标准化碘浓度及曲线斜率在鳞癌与腺癌间差异无统计学意义。
  • 「碘浓度+标准化碘浓度+曲线斜率」联合诊断效能最高(AUC 0.891),但敏感度较低。

核心结论

  • 静脉期增强双能CT提取的碘定量参数可能有助于区分肺鳞状细胞癌与腺癌;单次静脉期扫描的评估可能替代其他期相扫描。

研究设计与样本

  • 单中心研究,纳入62例肺癌患者(32例鳞状细胞癌、30例腺癌),行双期增强双能CT(动脉期与静脉期),测量病灶碘浓度、标准化碘浓度及曲线斜率,以病理类型为参考标准,采用ROC曲线分析。

关键影像表现/征象

  • 腺癌的碘浓度、标准化碘浓度及曲线斜率在两个扫描期相均高于鳞状细胞癌。
  • 上述参数在两种病理类型间的差异仅在静脉期有统计学意义,动脉期无统计学意义。

诊断标准与关键数值

  • 静脉期碘浓度鉴别鳞癌与腺癌的最佳阈值为1.550,敏感度81.2%、特异度83.3%、AUC 0.871。
  • 静脉期标准化碘浓度最佳阈值为0.227,敏感度56.2%、特异度93.3%、AUC 0.800。
  • 静脉期曲线斜率最佳阈值为1.608,敏感度65.6%、特异度80%、AUC 0.720。
  • 静脉期碘浓度+标准化碘浓度联合的敏感度81.3%、特异度83.3%、AUC 0.874。
  • 静脉期碘浓度+标准化碘浓度+曲线斜率联合的敏感度68.8%、特异度93.3%、AUC 0.891,诊断效能最高但敏感度低。

临床应用与阅片要点

  • 阅片时可在静脉期测量病灶碘浓度、标准化碘浓度及曲线斜率,腺癌参数均高于鳞癌。
  • 单一碘浓度参数在静脉期具有较高敏感度和特异度,联合标准化碘浓度可保持相近诊断效能。
  • 联合三项参数虽诊断效能最高,但敏感度较低,作者指出碘浓度与碘浓度+标准化碘浓度诊断效能略低但敏感度和特异度较高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To investigate whether iodine quantification extracted from enhanced dual energy-computed tomography (DE-CT) is useful for distinguishing lung squamous cell carcinoma from adenocarcinoma and to evaluate whether a single scan evaluated during the venous phase (VP) can be substituted for scans evaluated during other phases.

MATERIALS AND METHODS: Sixty-two patients with lung cancer (32 squamous cell carcinomas; 30 adenocarcinomas) underwent enhanced dual-phase DE-CT scans, including an arterial phase and VP. The iodine concentration (IC), normalized iodine concentration (NIC), and slope of the curve (K) in lesions were measured during two scanning phases in two different pathological types of lung cancers. The differences in parameters (IC, NIC, and K) between these two types of lung cancers were statistically analyzed. In addition, the receiver operating characteristic curves of these parameters were performed to discriminate squamous cell carcinoma from adenocarcinoma.

RESULTS: The mean IC, NIC, and K in adenocarcinomas were all higher than those in squamous cell carcinomas during the two scanning phases. However, the differences in these parameters between the two types of cancers were significant only during the VP, not during the arterial phase. Receiver operating characteristic analysis demonstrated that the optimal thresholds of the IC, NIC, and K for discriminating squamous cell carcinoma from adenocarcinoma were 1.550, 0.227, and 1.608, respectively. In addition, the sensitivity, specificity, and area under the curve were 81.2%, 83.3%, and 0.871 for the IC; 56.2%, 93.3%, and 0.800 for the NIC; and 65.6%, 80%, and 0.720 for the K; 81.3%, 83.3%, and 0.874 for the IC + NIC; 68.8%, 93.3%, and 0.891 for the IC + NIC + K, respectively. The "IC + NIC + K" had the highest diagnostic efficiency for discriminating two types of lung cancers, but with low sensitivity. Whereas, "IC"and "IC + NIC" had the similar lower diagnostic efficiency, but with high sensitivity and specificity.

CONCLUSION: The iodine quantification parameters derived from enhanced DE-CT during the VP may be useful for distinguishing lung squamous cell carcinoma from adenocarcinoma.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Zhang Z, Zou H, Yuan A, et al. A Single Enhanced Dual-Energy CT Scan May Distinguish Lung Squamous Cell Carcinoma From Adenocarcinoma During the Venous phase. Acad Radiol. 2019. PMID: 31447258. doi:10.1016/j.acra.2019.07.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。